,,iv #aagth ,,congress #ast ,session ,h4 ,,res4 #dhd ,,in ,,the ,,house ,,of ,,representatives ,june #ag1 #bjba,mrs4 ,miller-,meeks 7for herself1 ,mrs4 ,fischbach1 ,mr4 ,jordan1 ,mr4 ,norman1 ,mr4 ,gibbs1 ,mr4 ,van ,drew1 ,mr4 ,budd1 ,mr4 ,hice of ,georgia1 ,mr4 ,green of ,tennessee1 ,mrs4 ,hinson1 ,mr4 ,rutherford1 ,mrs4 ,wagner1 ,ms4 ,mace1 ,mr4 ,duncan1 ,mr4 ,owens1 ,mr4 ,c4 ,scott ,franklin of ,florida1 ,mr4 ,burchett1 ,mr4 ,hudson1 ,ms4 ,malliotakis1 ,mr4 ,emmer1 and ,ms4 ,cheney7 submitted the following resolution2 which was referred to the ,committee on the ,judiciary ,,resolution ,expressing the sense of the ,house of ,representatives that the ,united ,states should not waive intellectual property rights relating to ,,covid-#ai vaccines or treatments4 ,whereas building on decades of research and in conjunction with ,operation ,warp ,speed1 the ,united ,states pharmaceutical industry successfully developed three incredibly effective ,,covid-#ai vaccines to date1 with a fourth vaccine currently undergoing clinical trials2 ,whereas these vaccines are the most respected1 most sought after vaccines in the world due to their exceptional efficacy and safety1 which is due to both the painstaking work and investment during development as well as the diligent efforts of the ,united ,states pharmaceutical industry to qualify and oversee world-class manufacturing facilities to produce the vaccines2 ,whereas intellectual property protections are vital to incentivize innovation1 including the innovations that directly led to the ,,covid-#ai vaccines and may revolutionize future vaccine development efforts2 and ,whereas intellectual property protections have not contributed significantly to shortages of ,,covid-#ai vaccines or had a significant effect on the pace of vaccinations1 both of which are predominantly dependent on logistical challenges1 raw material shortages1 and other factors3 ,now1 therefore1 be it that it is the sense of the ,house of ,representatives that-- 7#a7 the policy of the ,united ,states should not be to waive valid intellectual property protections for ,,covid-#ai vaccines or treatments1 related manufacturing processes or technology1 technology platforms used to develop ,,covid-#ai vaccines or other medicines1 or other related innovations2 and 7#b7 the policy of the ,united ,states should not be to strip innovators of valid intellectual property protections because it would undermine innovation1 weaken the competitiveness of ,united ,states businesses1 and damage our ability to respond to future pandemics4